Fetal health testing instruments is a set of medical devices used to check the health conditions of a fetus. Health conditions include fetus movement, heart rate, maternal contractions, and overall fetal growth. Fetal health testing instruments check whether pre-term labor medicines are affecting the baby or not. Fetal health testing instruments are used in tests such as the contraction stress test, biophysical profile, and non-stress test that includes the combination of an ultrasound and non-stress test. Pushing or contractions during the second stage of labor may also affect the fetus heart rate. In these conditions, fetal health testing instruments play a very important role to overcome the complications.
These factors increase the market growth of fetal health testing instruments. From the past few years, the demand for fetal health testing instruments has increased significantly, owing to the increasing need and demand to reduce stillbirths. According to the WHO, in 2015, there were around 2.6 Mn stillbirths. Out of these, more than 30% deaths per day. The majority of these deaths are observed in developing countries. However, with the introduction of different fetal screening & testing procedures and fetal health testing instruments, the number of stillbirths has declined. In addition, active government and non-government initiatives for improving fetal and maternal health have raised the demand for fetal health testing instruments worldwide.
Request Sample Report@ https://www.persistencemarketresearch.com/samples/26269
An increasing number of pre-term births, post-term pregnancy, maternal infections & disorders, premature delivery cases, and multiple pregnancies are some of the reasons for the growth of fetal health testing instruments market. Increase in pre-term births incidence is one of the primary factors responsible for fetal health testing instruments market. Normally, pre-mature babies have many complications because of early birth before completing overall development inside the womb. The medical difficulties of pre-term birth can be easily diagnosed with fetal health testing instruments. The fetal health testing instruments reduce the possibility of newborn deaths caused by complications and reduce the probability of disabilities such as visual or hearing problems. These factors are contributing to the growth of fetal health testing instruments market. However, lack of awareness and negligence of complication at an early stage may hamper the market growth of fetal health testing instruments.
The global market for fetal health testing instruments is segmented on basis of product type, method, end user and geography.
Request For TOC @ https://www.persistencemarketresearch.com/toc/26269
On the basis of geography, the global fetal health testing instruments market is segmented into six key regions viz. North America, Latin America, Europe, the Asia Pacific excluding China, China, and the Middle East & Africa. The North America fetal health testing instruments market is expected to show maximum market share in the global market, followed by Europe, due to increased high healthcare spending and advanced infrastructure. However, Asia Pacific region is expected to show the highest CAGR during the forecast period due to the growing population and high birth rate. However, the market for fetal health testing instruments in Latin America, and the Middle East and Africa regions are estimated to show a slow growth over the forecast period due to low healthcare facilities and lack of awareness.
Examples of some of the key players present in the global fetal health testing instruments market are Huntleigh Healthcare Limited, Progetti srl, Sunray Medical Apparatus Co., Ltd, Promed Group Co., Ltd., Koninklijke Philips N.V., Laerdal Medical., Informa Life Sciences, GE Healthcare, Shenzhen Bestman Instrument Co., ltd, Natus Medical Incorporated., CooperSurgical Inc. and others.
These factors increase the market growth of fetal health testing instruments. From the past few years, the demand for fetal health testing instruments has increased significantly, owing to the increasing need and demand to reduce stillbirths. According to the WHO, in 2015, there were around 2.6 Mn stillbirths. Out of these, more than 30% deaths per day. The majority of these deaths are observed in developing countries. However, with the introduction of different fetal screening & testing procedures and fetal health testing instruments, the number of stillbirths has declined. In addition, active government and non-government initiatives for improving fetal and maternal health have raised the demand for fetal health testing instruments worldwide.
Request Sample Report@ https://www.persistencemarketresearch.com/samples/26269
An increasing number of pre-term births, post-term pregnancy, maternal infections & disorders, premature delivery cases, and multiple pregnancies are some of the reasons for the growth of fetal health testing instruments market. Increase in pre-term births incidence is one of the primary factors responsible for fetal health testing instruments market. Normally, pre-mature babies have many complications because of early birth before completing overall development inside the womb. The medical difficulties of pre-term birth can be easily diagnosed with fetal health testing instruments. The fetal health testing instruments reduce the possibility of newborn deaths caused by complications and reduce the probability of disabilities such as visual or hearing problems. These factors are contributing to the growth of fetal health testing instruments market. However, lack of awareness and negligence of complication at an early stage may hamper the market growth of fetal health testing instruments.
The global market for fetal health testing instruments is segmented on basis of product type, method, end user and geography.
- Segmentation by Product Type
- Ultrasound
- Doppler Imaging
- Electronic Fetal Monitoring (EFM)
- Intrauterine Pressure Catheter (IUPC)
- Fetal Doppler
- Telemetry Solutions
- Fetal Electrodes
- Segmentation by Method
- Invasive
- Non-Invasive
- Segmentation by End User
- Hospitals
- Gynecology Clinics
- Others
Request For TOC @ https://www.persistencemarketresearch.com/toc/26269
On the basis of geography, the global fetal health testing instruments market is segmented into six key regions viz. North America, Latin America, Europe, the Asia Pacific excluding China, China, and the Middle East & Africa. The North America fetal health testing instruments market is expected to show maximum market share in the global market, followed by Europe, due to increased high healthcare spending and advanced infrastructure. However, Asia Pacific region is expected to show the highest CAGR during the forecast period due to the growing population and high birth rate. However, the market for fetal health testing instruments in Latin America, and the Middle East and Africa regions are estimated to show a slow growth over the forecast period due to low healthcare facilities and lack of awareness.
Examples of some of the key players present in the global fetal health testing instruments market are Huntleigh Healthcare Limited, Progetti srl, Sunray Medical Apparatus Co., Ltd, Promed Group Co., Ltd., Koninklijke Philips N.V., Laerdal Medical., Informa Life Sciences, GE Healthcare, Shenzhen Bestman Instrument Co., ltd, Natus Medical Incorporated., CooperSurgical Inc. and others.
No comments:
Post a Comment